Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine if pulmonary rehabilitation has any effect on breathlessness, quality of life, physical function and depression in persons with interstitial lung disease.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pulmonary rehabilitation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pulmonary rehabilitation | Other | Structured education and supervised exercise program, lasting between 6 and 9 weeks. |
|
| Measure | Description | Time Frame |
|---|---|---|
| 6-minute walk distance | Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation | |
| Quality of life | Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation |
| Measure | Description | Time Frame |
|---|---|---|
| Dyspnea | Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation | |
| Depression | Immediately following completion of pulmonary rehabilitation and 6 months following the start of pulmonary rehabilitation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Any patient with interstitial lung disease who is referred to a participating pulmonary rehabilitation program. These patients typically have exercise limitation and dyspnea, but still possess the ability to perform some exercise.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Harold R Collard, MD | University of California, San Francisco | Principal Investigator |
| Christopher J Ryerson, MD | University of California, San Francisco | Principal Investigator |
| Chris Garvey, FNP | Seton Pulmonary & Cardiac Rehabilitation | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| John Muir Health | Concord | California | 94520 | United States | ||
| Seton Pulmonary & Cardiac Rehabilitation |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 24332409 | Derived | Ryerson CJ, Cayou C, Topp F, Hilling L, Camp PG, Wilcox PG, Khalil N, Collard HR, Garvey C. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med. 2014 Jan;108(1):203-10. doi: 10.1016/j.rmed.2013.11.016. Epub 2013 Dec 4. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D017563 | Lung Diseases, Interstitial |
| D011658 | Pulmonary Fibrosis |
| D051346 | Mobility Limitation |
| D004417 | Dyspnea |
| D000092862 | Psychological Well-Being |
| ID | Term |
|---|---|
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D005355 | Fibrosis |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
| Daly City |
| California |
| 94015 |
| United States |
| Yale University School of Medicine | New Haven | Connecticut | 06520-8057 | United States |
| Duke University Medical Center | Durham | North Carolina | 27710 | United States |
| Inova Fairfax Hospital | Falls Church | Virginia | 22042 | United States |
| University of British Columbia | Vancouver | British Columbia | V6Z 1Y6 | Canada |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D012816 | Signs and Symptoms |
| D012120 | Respiration Disorders |
| D012818 | Signs and Symptoms, Respiratory |
| D010549 | Personal Satisfaction |
| D001519 | Behavior |